Quest Diagnostics is a publicly listed company tracked for investment-relevant business developments.
Traditional lab incumbents (Quest, LabCorp) are built for steady-state efficiency (1% margin gains) and cannot scale 10x rapidly during demand surges because their supply chains, automation, and culture are optimized for stability not elasticity.